The University of Southampton
University of Southampton Institutional Repository

Examining the microglial TSPO phenotype in Alzheimer’s disease

Examining the microglial TSPO phenotype in Alzheimer’s disease
Examining the microglial TSPO phenotype in Alzheimer’s disease
Background: neuroinflammation is a key pathological feature of Alzheimer’s disease (AD), with microglia being the main inflammatory cell type in the CNS. In order to examine these cells in vivo, PET ligands targeting the microglial translocator protein (TSPO) have been developed. However, it remains unclear the specific target of these ligands, whether this is all microglia or a subset of cells. We aim to elucidate this by identifying the microglial phenotype most associated with TSPO in humans.

Method: human post-mortem sections of temporal lobe (TL) and cerebellum (Cb) from cases classified by Braak stage (0-II, III-IV, V-VI; each n = 10) were immunostained for pan-Aß, pTau, and microglial markers TSPO, Iba1 and HLA-DR with protein load quantified. Double immunofluorescent staining was performed with TSPO and microglial markers HLA-DR and CD68 with positive cells counted.

Result: TL showed an increase in Aβ (P<0.0001), pTau (P<0.0001) and TSPO (P<0.0001) protein load, but not Iba1 or HLA-DR, with progressing Braak stage. Aβ (P = 0.0008) and Iba1 (P = 0.012) load increased in the Cb, but not pTau, TSPO or HLA-DR. Of note, TSPO load in TL was associated with pTau. In both areas, no difference was found in number of HLA+ or CD68+ cells, though TL TSPO+ cell number increased significantly (P = 0.0347). There was no difference in the number of HLA-DR+/TSPO+ or CD68+/TSPO+ cells with progressing Braak stage. However, significantly more CD68+/TSPO+ than HLA-DR+/TSPO+ cells were detected in both the TL (P<0.0001) and Cb (P = 0.009) regions.

Conclusion: the results suggest that TSPO expression is related to late stage disease (pTau) and microglial phagocytosis (CD68), a function we have previously identified associated with the presence of dementia, cognitive decline and tau pathology. Further additional analysis with other microglial markers is currently ongoing.
1552-5260
Garland, Emma F.
b59c66f2-ac4c-4d8d-823d-687769deccce
Kulagowska, Laura
97aa0e3a-d4e5-4137-a845-850b2d2f5933
Scott, Thomas
651073ff-87d8-42a9-a25d-c2a663fcb449
Antony, Henrike
34d46cf2-833a-4272-82e2-41e082fa8c68
Bottlaender, Michel
7ec76930-cf42-4f7b-8801-fbb3789eabed
Nicoll, James A.
88c0685f-000e-4eb7-8f72-f36b4985e8ed
Boche, Delphine
bdcca10e-6302-4dd0-919f-67218f7e0d61
et al.
Garland, Emma F.
b59c66f2-ac4c-4d8d-823d-687769deccce
Kulagowska, Laura
97aa0e3a-d4e5-4137-a845-850b2d2f5933
Scott, Thomas
651073ff-87d8-42a9-a25d-c2a663fcb449
Antony, Henrike
34d46cf2-833a-4272-82e2-41e082fa8c68
Bottlaender, Michel
7ec76930-cf42-4f7b-8801-fbb3789eabed
Nicoll, James A.
88c0685f-000e-4eb7-8f72-f36b4985e8ed
Boche, Delphine
bdcca10e-6302-4dd0-919f-67218f7e0d61

Garland, Emma F., Kulagowska, Laura and Scott, Thomas , et al. (2023) Examining the microglial TSPO phenotype in Alzheimer’s disease. Alzheimer's & Dementia, 19 (S13), [e073305]. (doi:10.1002/alz.073305).

Record type: Meeting abstract

Abstract

Background: neuroinflammation is a key pathological feature of Alzheimer’s disease (AD), with microglia being the main inflammatory cell type in the CNS. In order to examine these cells in vivo, PET ligands targeting the microglial translocator protein (TSPO) have been developed. However, it remains unclear the specific target of these ligands, whether this is all microglia or a subset of cells. We aim to elucidate this by identifying the microglial phenotype most associated with TSPO in humans.

Method: human post-mortem sections of temporal lobe (TL) and cerebellum (Cb) from cases classified by Braak stage (0-II, III-IV, V-VI; each n = 10) were immunostained for pan-Aß, pTau, and microglial markers TSPO, Iba1 and HLA-DR with protein load quantified. Double immunofluorescent staining was performed with TSPO and microglial markers HLA-DR and CD68 with positive cells counted.

Result: TL showed an increase in Aβ (P<0.0001), pTau (P<0.0001) and TSPO (P<0.0001) protein load, but not Iba1 or HLA-DR, with progressing Braak stage. Aβ (P = 0.0008) and Iba1 (P = 0.012) load increased in the Cb, but not pTau, TSPO or HLA-DR. Of note, TSPO load in TL was associated with pTau. In both areas, no difference was found in number of HLA+ or CD68+ cells, though TL TSPO+ cell number increased significantly (P = 0.0347). There was no difference in the number of HLA-DR+/TSPO+ or CD68+/TSPO+ cells with progressing Braak stage. However, significantly more CD68+/TSPO+ than HLA-DR+/TSPO+ cells were detected in both the TL (P<0.0001) and Cb (P = 0.009) regions.

Conclusion: the results suggest that TSPO expression is related to late stage disease (pTau) and microglial phagocytosis (CD68), a function we have previously identified associated with the presence of dementia, cognitive decline and tau pathology. Further additional analysis with other microglial markers is currently ongoing.

Text
AAIC 2023 abstract - Accepted Manuscript
Download (14kB)

More information

Published date: 25 December 2023
Additional Information: Poster presentation

Identifiers

Local EPrints ID: 487532
URI: http://eprints.soton.ac.uk/id/eprint/487532
ISSN: 1552-5260
PURE UUID: 8d40f4b1-1fad-48d7-8441-e577ac071bbf
ORCID for Emma F. Garland: ORCID iD orcid.org/0000-0002-8501-4326
ORCID for James A. Nicoll: ORCID iD orcid.org/0000-0002-9444-7246
ORCID for Delphine Boche: ORCID iD orcid.org/0000-0002-5884-130X

Catalogue record

Date deposited: 22 Feb 2024 18:40
Last modified: 13 Apr 2024 02:01

Export record

Altmetrics

Contributors

Author: Emma F. Garland ORCID iD
Author: Laura Kulagowska
Author: Thomas Scott
Author: Henrike Antony
Author: Michel Bottlaender
Author: James A. Nicoll ORCID iD
Author: Delphine Boche ORCID iD
Corporate Author: et al.

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×